Drug Type Small molecule drug |
Synonyms IMPHY000366 |
Target |
Action inhibitors |
Mechanism Aurora B inhibitors(Serine/threonine-protein kinase Aurora-B inhibitors), CDK1 inhibitors(Cyclin-dependent kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | India | 21 Nov 2025 |





